Antibodies against a β-glucan-protein complex of Candida albicans and its potential as indicator of protective immunity in candidemic patients

Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy

(2016) Sara Tedeschi et al.   European Journal of Internal Medicine

Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study

(2016) Roberto Luzzati et al.   INFECTION

Invasive Candidiasis

(2016) Todd P. McCarty et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Epidemiology, microbiology, clinical characteristics, and outcomes of candidemia in internal medicine wards—a retrospective study

(2016) Noa Eliakim-Raz et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study

(2016) Brunella Posteraro et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Immunoproteomic Analysis of Antibody Responses to Extracellular Proteins of Candida albicans Revealing the Importance of Glycosylation for Antigen Recognition

(2016) Ting Luo et al.   JOURNAL OF PROTEOME RESEARCH

Seroprofiling at the Candida albicans protein species level unveils an accurate molecular discriminator for candidemia

(2016) Aida Pitarch et al.   Journal of Proteomics

Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne over Nine Years at a Large Italian Teaching Hospital

(2015) Brunella Posteraro et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Adaptations of the Secretome of Candida albicans in Response to Host-Related Environmental Conditions

(2015) Frans M. Klis et al.   EUKARYOTIC CELL

Non-cultural methods for the diagnosis of invasive fungal disease

(2014) Małgorzata Mikulska et al.   Expert Review of Anti-Infective Therapy

A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality

(2014) Matteo Bassetti et al.   INTENSIVE CARE MEDICINE

Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-year period

(2014) Arnaldo L. Colombo et al.   INTENSIVE CARE MEDICINE

Identification and management of invasive mycoses in internal medicine: a road-map for physicians

(2014) Marco Falcone et al.   Internal and Emergency Medicine

Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia

(2014) M. Carmen Martínez-Jiménez et al.   MEDICAL MYCOLOGY

Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008

(2014) Michael A. Pfaller et al.   PLoS One

Epidemiology and risk factors for invasive candidiasis

(2014) Nur Yapar   Therapeutics and Clinical Risk Management

A 1-year prospective survey of candidemia in Italy and changing epidemiology over one decade

(2013) A. M. Tortorano et al.   INFECTION

Comparison of (1->3)- -D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia

(2013) J. Held et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008

(2012) Michael Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Cytokine Gene Polymorphisms and the Outcome of Invasive Candidiasis: A Prospective Cohort Study

(2011) Melissa D. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Potential of anti-Candidaantibodies in immunoprophylaxis

(2010) Jonathan Cabezas et al.   Immunotherapy

β-glucan recognition by the innate immune system

(2009) Helen S. Goodridge et al.   IMMUNOLOGICAL REVIEWS

Use of 65kDa mannoprotein gene primers in PCR methods for the identification of five medically important Candida species

(2009) S. Arancia et al.   MOLECULAR AND CELLULAR PROBES

Antibodies against Glucan, Chitin, and Saccharomyces cerevisiae Mannan as New Biomarkers of Candida albicans Infection That Complement Tests Based on C. albicans Mannan

(2008) B. Sendid et al.   Clinical and Vaccine Immunology

Anti-β-glucan antibodies in healthy human subjects

(2008) P. Chiani et al.   VACCINE